CervoMed CRVO
NASDAQ CRVO
$2.99 +0.06 (+2.05%)
As of: Oct 2, 2026 · 10:56 AM EDT

CervoMed (CRVO) Return on Equity [ROE] (2011 - 2026)

Updated

CervoMed (CRVO) posted Return on Equity [ROE] of -180.80% for Q2 2026, down 114.40 percentage points from -66.40% a year earlier but up 27.44 percentage points from the prior quarter.

Analysis

CervoMed (CRVO) Return on Equity [ROE] (2011 - 2026) Analysis & Trends

For FY2025, CervoMed's Return on Equity [ROE] came in at -93.89%, down 23.94 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of -30.77 percentage points (FY2020 to FY2025).
  • In prior years, CervoMed's Return on Equity [ROE] was -69.94% in FY2024.
  • Quarterly Return on Equity [ROE] has run from a low of -1765.00% in Q1 2022 to a high of -24.98% in Q3 2024 over five years.
  • On a year-over-year basis, Return on Equity [ROE] has declined in each of the last five quarters, with an average year-over-year change of -44.25 percentage points over the last seven quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2025, with a gain of 86.56 percentage points; the weakest was Q1 2022, with a drop of 1723.52 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -208.24% (Q1 2026), -121.89% (Q4 2025) and -86.04% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 CervoMed 30.43 Mn 30.43 Mn - -180.80%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -180.80%
Mar 31, 2026 -208.24%
Dec 31, 2025 -121.89%
Sep 30, 2025 -86.04%
Jun 30, 2025 -66.40%
Mar 31, 2025 -50.57%
Dec 31, 2024 -38.40%
Sep 30, 2024 -24.98%
Jun 30, 2024 -35.51%
Mar 31, 2024 -137.13%
Dec 31, 2023 -89.59%
Mar 31, 2022 -1,765.00%
Dec 31, 2021 -465.16%
Sep 30, 2021 -55.91%
Jun 30, 2021 -32.60%
Mar 31, 2021 -41.47%
Dec 31, 2020 -52.99%
Sep 30, 2020 -45.05%
Jun 30, 2020 -48.21%
Mar 31, 2020 -61.05%
API Access

CervoMed Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRVO&period=max&api_key=YOUR_API_KEY